tiprankstipranks
Advertisement
Advertisement
Jazz Pharmaceuticals price target raised to $285 from $265 at Wells Fargo
PremiumThe FlyJazz Pharmaceuticals price target raised to $285 from $265 at Wells Fargo
8d ago
Jazz Pharmaceuticals price target raised to $260 from $253 at Barclays
Premium
The Fly
Jazz Pharmaceuticals price target raised to $260 from $253 at Barclays
8d ago
Jazz Pharmaceuticals price target raised to $270 from $250 at Deutsche Bank
Premium
The Fly
Jazz Pharmaceuticals price target raised to $270 from $250 at Deutsche Bank
13d ago
Jazz announces eleven presentations at SLEEP 2026
PremiumThe FlyJazz announces eleven presentations at SLEEP 2026
1M ago
RedHill (RDHL) Gains FDA Rare Pediatric Disease Designation, Opening Door to Potential Priority Review Voucher (PRV) Upside
Premium
Market NewsSponsored
RedHill (RDHL) Gains FDA Rare Pediatric Disease Designation, Opening Door to Potential Priority Review Voucher (PRV) Upside
1M ago
Morning Movers: EchoStar and Rocket Lab lift off ahead of SpaceX IPO
Premium
The Fly
Morning Movers: EchoStar and Rocket Lab lift off ahead of SpaceX IPO
1M ago
Jessica Fye Reaffirms Buy on Jazz Pharmaceuticals, Citing Blockbuster Potential for Zanidatamab in First-Line HER2-Positive Gastric and Esophageal Cancers
PremiumRatingsJessica Fye Reaffirms Buy on Jazz Pharmaceuticals, Citing Blockbuster Potential for Zanidatamab in First-Line HER2-Positive Gastric and Esophageal Cancers
2M ago
Jazz Pharmaceuticals announces planned board leadership transition
Premium
Company Announcements
Jazz Pharmaceuticals announces planned board leadership transition
2M ago
Jazz Pharmaceuticals Phase 3 HERIZON-GEA-01 results published in NEJM
Premium
The Fly
Jazz Pharmaceuticals Phase 3 HERIZON-GEA-01 results published in NEJM
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100